Physician profile
Mark A Orso
NPI 1902956964
$2,775.94
in general payments reported to CMS, 2019-2025
12 companies · $1,340 in 2025
The $1,340 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $82.34 · 2021: $70.98 · 2022: $44.25 · 2023: $383 · 2024: $473 · 2025: $1,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163 · Travel and Lodging: $925 · Entertainment: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.22 |
| Travel and Lodging | $924.96 |
| Entertainment | $107.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,449.58 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $310.31 | 2021-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $218.83 | 2023-2025 | Infuse |
| Coopervision INC. | $132.00 | 2019-2025 | Misight Contact Lens, Clariti Contact Lens |
| Optovue, INC. | $116.66 | 2019 | |
| Optos, INC. | $107.76 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Rxsight INC | $104.39 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Harrow Eye, LLC | $97.85 | 2025 | Vevye |
| Abb Con-Cise Optical Group LLC | $92.59 | 2019-2021 | |
| Visioneering Technologies, INC. | $86.93 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.80 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Orso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.